UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

Critical reviews in oncology/hematology, 2016-04, Vol.100, p.107-116

2016

Volltextzugriff (PDF)

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-07, Vol.133, p.130-135

2019

Volltextzugriff (PDF)

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.179-186

2019

Volltextzugriff (PDF)

Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial

European journal of cancer (1990), 2017-02, Vol.72, p.37-45

2017

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic

Critical reviews in oncology/hematology, 2007-01, Vol.61 (1), p.52-69

2007

Volltextzugriff (PDF)

Costs of non-small cell lung cancer in the Netherlands

Lung cancer (Amsterdam, Netherlands), 2016-01, Vol.91, p.79-88

2016

Volltextzugriff (PDF)

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-11, Vol.82 (2), p.276-281

2013

Volltextzugriff (PDF)

Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer: Results From the ROSEL Randomized Controlled Trial and a Systematic Review

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S10-S11

2016

Volltextzugriff (PDF)

Health Economic Impact of Volume Doubling Time as Biomarker in Lung Cancer Diagnosis

Value in health, 2014-11, Vol.17 (7), p.A655-A655

2014

Volltextzugriff (PDF)

Blinded and uniform cause of death verification in a lung cancer CT screening trial

Lung cancer (Amsterdam, Netherlands), 2012-09, Vol.77 (3), p.522-525

2012

Volltextzugriff (PDF)

'DE NOVO' Quantification of Genotype-Directed Therapy with Afatinib in Metastatic Lung Cancer

Value in health, 2014-11, Vol.17 (7), p.A641-A641

2014

Volltextzugriff (PDF)

PD-0135: Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiatioN

Radiotherapy and oncology, 2014, Vol.111, p.S53-S53

2014

Volltextzugriff (PDF)

OC-0164 METASTASECTOMY NOT BETTER THAN SABR FOR LUNG OLIGOMETASTASES IN A SINGLE INSTITUTION COHORT (N=110)

Radiotherapy and oncology, 2012-05, Vol.103, p.S63-S63

2012

Volltextzugriff (PDF)

OC-0326: Coregistration of 18F-FAZA- and 18F-FDG-PET in NSCLC

Radiotherapy and oncology, 2013-03, Vol.106, p.S126-S126

2013

Volltextzugriff (PDF)

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Lung cancer (Amsterdam, Netherlands), 2008-03, Vol.59 (3), p.385-390

2008

Volltextzugriff (PDF)

9028 POSTER Gemcitabine and Cisplatin Followed by Concurrent Gemcitabine and Radiotherapy or Sequential Radiotherapy Alone in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

European journal of cancer (1990), 2011, Vol.47, p.S600-S600

2011

Volltextzugriff (PDF)

A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation

European journal of cancer (1990), 2011, Vol.47, p.14-14

2011

Volltextzugriff (PDF)

Molecular Tumor Boards: current practice and future needs

Annals of oncology, 2017-12, Vol.28 (12), p.3070-3075

2017

Volltextzugriff (PDF)

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

European journal of cancer (1990), 2019-08, Vol.117, p.60-68

2019

Volltextzugriff (PDF)

Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension

The European respiratory journal, 2000-08, Vol.16 (2), p.276-281

2000

Volltextzugriff (PDF)

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052

2014

Volltextzugriff (PDF)

986P Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study

Annals of oncology, 2022-09, Vol.33, p.S1003

2022

Volltextzugriff (PDF)

Circulating tumor cells are prognostic in SCLC, but still lack clinical application

Annals of oncology, 2019-07, Vol.30 (7), p.1031-1033

2019

Volltextzugriff (PDF)

486P Fiscal feasibility and implications of integrating lung cancer screening into Hong Kong’s healthcare system

Annals of oncology, 2023-11, Vol.34, p.S1651-S1652

2023

Volltextzugriff (PDF)

26P Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung Cancer (aNSCLC): Updated results from GEOMETRY mono-1

Annals of oncology, 2022-04, Vol.33, p.S42

2022

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(131)
Reviews
(2)

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(55)
Humans
(52)
Oncology
(49)
Female
(39)
Male
(39)
Aged
(35)
Middle Aged
(35)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Lung Neoplasms - Drug Therapy
(26)
Adult
(23)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(22)
Hematology, Oncology And Palliative Medicine
(20)
Pharmacology. Drug Treatments
(18)
Aged, 80 And Over
(15)
Antineoplastic Agents
(15)
Pneumology
(15)
Lung Neoplasms - Mortality
(14)
Respiratory System
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic

Costs of non-small cell lung cancer in the Netherlands

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer: Results From the ROSEL Randomized Controlled Trial and a Systematic Review

Health Economic Impact of Volume Doubling Time as Biomarker in Lung Cancer Diagnosis

Blinded and uniform cause of death verification in a lung cancer CT screening trial

'DE NOVO' Quantification of Genotype-Directed Therapy with Afatinib in Metastatic Lung Cancer

PD-0135: Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiatioN

OC-0164 METASTASECTOMY NOT BETTER THAN SABR FOR LUNG OLIGOMETASTASES IN A SINGLE INSTITUTION COHORT (N=110)

OC-0326: Coregistration of 18F-FAZA- and 18F-FDG-PET in NSCLC

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

9028 POSTER Gemcitabine and Cisplatin Followed by Concurrent Gemcitabine and Radiotherapy or Sequential Radiotherapy Alone in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation

Molecular Tumor Boards: current practice and future needs

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

986P Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study

Circulating tumor cells are prognostic in SCLC, but still lack clinical application

486P Fiscal feasibility and implications of integrating lung cancer screening into Hong Kong’s healthcare system

26P Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung Cancer (aNSCLC): Updated results from GEOMETRY mono-1

Suchergebnisse filtern